These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3097725)

  • 1. Effects of physostigmine on memory test performance in normal volunteers.
    Smith CM; Coogan JS; Hart S
    Psychopharmacology (Berl); 1986; 90(3):364-6. PubMed ID: 3097725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine: improvement of long-term memory processes in normal humans.
    Davis KL; Mohs RC; Tinklenberg JR; Pfefferbaum A; Hollister LE; Kopell BS
    Science; 1978 Jul; 201(4352):272-4. PubMed ID: 351807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physostigmine on stimulus encoding in a memory-scanning task.
    Wetherell A
    Psychopharmacology (Berl); 1992; 109(1-2):198-202. PubMed ID: 1365656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline chloride effects on memory: correlation with the effects of physostigmine.
    Mohs RC; Davis KL
    Psychiatry Res; 1980 May; 2(2):149-56. PubMed ID: 6932060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.
    Thal LJ; Masur DM; Blau AD; Fuld PA; Klauber MR
    J Am Geriatr Soc; 1989 Jan; 37(1):42-8. PubMed ID: 2642499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.
    Asthana S; Raffaele KC; Berardi A; Greig NH; Haxby JV; Schapiro MB; Soncrant TT
    Alzheimer Dis Assoc Disord; 1995; 9(4):223-32. PubMed ID: 8749612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.
    Muramoto O; Sugishita M; Sugita H; Toyokura Y
    Arch Neurol; 1979 Aug; 36(8):501-3. PubMed ID: 508162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine.
    Freo U; Ricciardi E; Pietrini P; Schapiro MB; Rapoport SI; Furey ML
    Am J Psychiatry; 2005 Nov; 162(11):2061-70. PubMed ID: 16263845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
    Mohs RC; Davis KL
    Neurobiol Aging; 1982; 3(2):105-10. PubMed ID: 6752738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine, auditory P300, and Alzheimer's disease.
    Friedman D
    Biol Psychiatry; 1988 Feb; 23(3):321-3. PubMed ID: 3337867
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    Mandel RJ; Chen AD; Connor DJ; Thal LJ
    J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine: effects on cognition and affect in normal subjects.
    Davis KL; Hollister LE; Overall J; Johnson A; Train K
    Psychopharmacology (Berl); 1976 Dec; 51(1):23-7. PubMed ID: 827772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of physostigmine and scopolamine on the memory functions of chess players.
    Liljequist R; Mattila MJ
    Med Biol; 1979; 57(6):402-5. PubMed ID: 547122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Ghoneim MM; Mewaldt SP
    Psychopharmacology (Berl); 1977 Mar; 52(1):1-6. PubMed ID: 403551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physostigmine and recent memory: effects in young and aged nonhuman primates.
    Bartus RT
    Science; 1979 Nov; 206(4422):1087-9. PubMed ID: 227061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.
    Mewaldt SP; Ghoneim MM
    Pharmacol Biochem Behav; 1979 Feb; 10(2):205-10. PubMed ID: 450929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of physostigmine on memory and auditory P300 in Alzheimer-type dementia.
    Blackwood DH; Christie JE
    Biol Psychiatry; 1986 May; 21(5-6):557-60. PubMed ID: 3697444
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
    Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.